☆ 4.4 Meeting Abstract

Pharmacokinetics and muscle distribution of AT2220, a pharmacological chaperone of acid-glucosidase, in healthy volunteers

MOLECULAR GENETICS AND METABOLISM (2011)

Journal

MOLECULAR GENETICS AND METABOLISM

Volume 102, Issue 2, Pages S4-S4

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE

DOI: 10.1016/j.ymgme.2010.11.011

Keywords

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4

Not enough ratings

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Pharmacokinetic Interaction between Atorvastatin and Omega-3 Fatty Acid in Healthy Volunteers

Jae Hoon Kim, Jung Sunwoo, Ji Hye Song, Yu-Bin Seo, Won Tae Jung, Kyu-Yeol Nam, YeSeul Kim, Hye Jung Lee, JungHa Moon, Jin-Gyu Jung, Jang Hee Hong

Summary: The interaction between atorvastatin and omega-3 fatty acids was evaluated in a phase 1 trial, and it was found that co-administration of the two drugs affected their concentrations, indicating a drug-drug interaction.

PHARMACEUTICALS (2022)

Add to Collection

Article Infectious Diseases

Probenecid effects on cephalexin pharmacokinetics and pharmacodynamics in healthy volunteers

Richard J. Everts, Sharon J. Gardiner, Mei Zhang, Ronald Begg, Stephen T. Chambers, John Turnidge, Evan J. Begg

Summary: This study evaluated the effects of probenecid on the pharmacokinetics and pharmacodynamics of oral cephalexin in healthy volunteers. Results showed that probenecid increased cephalexin plasma concentrations and prolonged half-life, enhancing the likelihood of reaching PK/PD targets. Co-administration of probenecid may expand the clinical benefits of oral cephalexin.

JOURNAL OF INFECTION (2021)

Add to Collection

Article Pharmacology & Pharmacy

Effect of CYP4F2 Polymorphisms on Ticagrelor Pharmacokinetics in Healthy Chinese Volunteers

Shanshan Nie, Kaifeng Chen, Chengxian Guo, Qi Pei, Chan Zou, Liangyuan Yao, Hongbo Yuan, Xia Zhao, Ran Xie, Xu He, Jie Huang, Guoping Yang

Summary: This study reveals the impact of CYP4F2 rs2074900 SNP on ticagrelor pharmacokinetics (PK) and provides new insights into the pharmacogenetics of ticagrelor.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection

Article Pharmacology & Pharmacy

Safety, tolerance, and pharmacokinetics of salvianolic acid B in healthy Chinese volunteers: A randomized, double-blind, placebo-controlled phase 1 clinical trial

Junlin Cheng, Jun Long, Jingjing Zhang, Le Han, Yunfang Hu, Jianghui Liu, Runze Qiu, Zhibin Zhu, Hongwei Fan

Summary: This study aimed to evaluate the safety, tolerance, and pharmacokinetics of Sal B injection in healthy Chinese volunteers. The results showed that single doses up to 300 mg and 250 mg for 5 consecutive days of Salvianolic acid B injections showed excellent safety and tolerability.

FRONTIERS IN PHARMACOLOGY (2023)

Add to Collection

Article Anesthesiology

Pharmacokinetics of tranexamic acid after intravenous, intramuscular, and oral routes: a prospective, randomised, crossover trial in healthy volunteers

Stanislas Grassin-Delyle, Michaela Semeraro, Elodie Lamy, Saik Urien, Ileana Runge, Frantz Foissac, Naim Bouazza, Jean-Marc Treluyer, Monica Arribas, Ian Roberts, Haleema Shakur-Still

Summary: The study showed significant differences in pharmacokinetics between intramuscular and oral administration of TXA in healthy volunteers, with intramuscular absorption being rapid and complete, making it a potentially effective alternative to intravenous TXA. Adverse events were mild and transient, mainly consisting of local reactions and low-intensity pain.

BRITISH JOURNAL OF ANAESTHESIA (2022)

Add to Collection

Article Gastroenterology & Hepatology

Clinical Study of Single-Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis B

Edward Gane, Man-Fung Yuen, Dong Joon Kim, Henry Lik-Yuen Chan, Bernadette Surujbally, Vedran Pavlovic, Sudip Das, Miriam Triyatni, Remi Kazma, Joseph F. Grippo, Simon Buatois, Annabelle Lemenuel-Diot, Ben-Fillippo Krippendorff, Henrik Mueller, Yuchen Zhang, Hyung Joon Kim, Apinya Leerapun, Tien Huey Lim, Young-Suk Lim, Tawesak Tanwandee, Won Kim, Wendy Cheng, Tsung-Hui Hu, Cynthia Wat

Summary: The study evaluated the safety and efficacy of RO7062931 in healthy volunteers and patients with chronic hepatitis B. Supradose-proportional increases in plasma exposure and urinary excretion of RO7062931 were observed at the same dosage. Patients exhibited dose-dependent reductions in HBsAg levels when treated with RO7062931.

HEPATOLOGY (2021)

Add to Collection

Article Pharmacology & Pharmacy

Physiologically based modelling of tranexamic acid pharmacokinetics following intravenous, intramuscular, sub-cutaneous and oral administration in healthy volunteers

Zoe Kane, Roberto Picetti, Alison Wilby, Joseph F. Standing, Stanislas Grassin-Delyle, Ian Roberts, Haleema Shakur-Still

Summary: The study suggests that intramuscular administration of TXA may achieve targeted exposure and capture variability in pharmacokinetics. Well-designed clinical trials are recommended to validate these findings.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2021)

Add to Collection

Article Microbiology

Drug-Drug Interaction Study of Benznidazole and E1224 in Healthy Male Volunteers

Isabela Ribeiro, Bethania Blum, Jayme Fernandes, Glaucia Santina, Makoto Asada, Michael Everson, Edgar Schuck, Ethel Feleder, Eric Evene, Virginie Gualano

Summary: The study evaluated the pharmacokinetics and safety interactions of BNZ and E1224 in healthy volunteers. The results showed changes in RVZ concentration parameters when both compounds were coadministered, but both compounds were well tolerated and no clinically relevant safety interactions were observed.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Add to Collection

Article Pharmacology & Pharmacy

Population pharmacokinetic analysis of transdermal granisetron in healthy Chinese and Caucasian volunteers

Jiayu Li, Pei Hu, Li Zhou, Fumiko Nagahama, Rui Chen

Summary: This study found ethnic differences in the pharmacokinetics of granisetron patches between Chinese and Caucasian populations, but analysis of a population pharmacokinetic model showed no significant differences in pharmacokinetic parameters between the two groups. Therefore, this study provides valuable insights for optimizing dosage across Chinese and Caucasian populations.

FRONTIERS IN PHARMACOLOGY (2023)

Add to Collection

Article Plant Sciences

Clinical pharmacokinetics of kavalactones after oral dosing of standardized kava extract in healthy volunteers

Siva Rama Raju Kanumuri, Jessica Mamallapalli, Robyn Nelson, Christopher R. McCurdy, Carol A. Mathews, Chengguo Xing, Abhisheak Sharma

Summary: This study examined the clinical pharmacokinetics of kava in healthy volunteers, finding higher exposure after single-dosing and longer duration of exposure after multiple doses.

JOURNAL OF ETHNOPHARMACOLOGY (2022)

Add to Collection

Article Infectious Diseases

Pharmacokinetics of chloroquine and primaquine in healthy volunteers

Andre Daher, Douglas Pereira Pinto, Lais Bastos da Fonseca, Heliana Martins Pereira, Diego Medeiros Dias da Silva, Leticia de Sa Fernandes Vallim da Silva, Alessandra Lanzillotta Esteves, Juliana J. Soares Medeiros, Jorge Souza Mendonca

Summary: This article presents the results of three bioequivalence studies that provide pharmacokinetic data on chloroquine and primaquine using up-to-date analytical methods. The results show that the tested formulations are bioequivalent, and the individual data provided may contribute to optimizing the treatment of vivax malaria.

MALARIA JOURNAL (2022)

Add to Collection

Article Pharmacology & Pharmacy

Pharmacokinetic Comparison of Ginsenosides between Fermented and Non-Fermented Red Ginseng in Healthy Volunteers

Myeong-Bae Shin, Sung-Ah Kim, Sooyoung Lee, Wang-Seob Shim, Kyung-Tae Lee, Seung-Kwon Lee, Sung-Vin Yim, Bo-Hyung Kim

Summary: Fermentation of red ginseng produces fermented red ginseng with increased downstream ginsenosides which have beneficial pharmacological effects and are easily absorbed by the human body. A clinical trial showed higher systemic exposure of ginsenosides, particularly CK and Rh2, after administration of fermented red ginseng compared to regular red ginseng.

PHARMACEUTICS (2022)

Add to Collection

Article Clinical Neurology

Electrical impedance myography in healthy volunteers

Michelle B. Offit, Hadi Mohammad Khanli, Tianxia Wu, Tanya J. Lehky

Summary: Electrical impedance myography (EIM) is a reproducible measure of muscle physiology. This study aimed to obtain EIM data from healthy volunteers (HVs), perform reliability tests on EIM outcome measures, and compare findings with muscle ultrasound variables.

MUSCLE & NERVE (2023)

Add to Collection

Article Health Care Sciences & Services

Effects of SLCO1B1 and SLCO1B3 Genetic Polymorphisms on Valsartan Pharmacokinetics in Healthy Korean Volunteers

Gonjin Song, Jee-Eun Chung, Jeong Yee, Kyung-Eun Lee, Kyungsoo Park, Hye-Sun Gwak

Summary: The study found that plasma exposure to valsartan is significantly decreased in carriers of SLCO1B1*1B and the rs4149153 T allele of SLCO1B3, possibly due to increased hepatic uptake.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Add to Collection

Article Endocrinology & Metabolism

Safety, Efficacy, and Pharmacokinetics of HP501 in Healthy Volunteers and Hyperuricemic Patients: A Phase I/IIa Study

Zhenlei Wang, Xinghai Li, Ying Jin, Runhan Liu, Xiangjie Di, Yi Zhou, Ying Wang, Lei Fan, Yuanwei Chen, Yongsheng Wang, Li Zheng

Summary: HP501 has shown acceptable safety and tolerability in both healthy volunteers and hyperuricemic patients, and it effectively reduces hyperuricemia. Further development of this drug is warranted.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Add to Collection

Article Medical Laboratory Technology

Novel Quantitative Method to Evaluate Globotriaosylceramide Inclusions in Renal Peritubular Capillaries by Virtual Microscopy in Patients With Fabry Disease

Laura Barisoni, J. Charles Jennette, Robert Colvin, Sheela Sitaraman, Alexander Bragat, Jeff Castelli, Dan Walker, Pol Boudes

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2012)

Add to Collection

Meeting Abstract Endocrinology & Metabolism

Novel quantitative method to evaluate GL-3 inclusions in renal peritubular capillaries (PTCs) in patients with Fabry disease (FD) by virtual microscopy (VM)

Laura Barisoni, Charles Jennette, Robert Colvin, Alexander Bragat, Jeff Castelli, Sheela Sitaraman, Pol Boudes

MOLECULAR GENETICS AND METABOLISM (2011)

Add to Collection

Meeting Abstract Endocrinology & Metabolism

Phase 3 study of migalastat HCl for Fabry disease: Stage 1 results

Kathy Nicholls, Dominique P. Germain, Claudio Feliciani, Suma Shankar, Fatih Ezgu, Salim G. Janmohamed, Shiona M. Laing, Rosemary O. Schroyer, Alex C. Bragat, Sheela Sitaraman, Pol F. Boudes

MOLECULAR GENETICS AND METABOLISM (2013)

Add to Collection

Article Endocrinology & Metabolism

A Phase 2 study of migalastat hydrochloride in females with Fabry disease: Selection of population, safety and pharmacodynamic effects

R. Giugliani, S. Waldek, D. P. Germain, K. Nicholls, D. G. Bichet, J. K. Simosky, A. C. Bragat, J. P. Castelli, E. R. Benjamin, P. F. Boudes

MOLECULAR GENETICS AND METABOLISM (2013)

Add to Collection

Article Genetics & Heredity

Safety and pharmacodynamic effects of a pharmacological chaperone on α-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies

Dominique P. Germain, Roberto Giugliani, Derralynn A. Hughes, Atul Mehta, Kathy Nicholls, Laura Barisoni, Charles J. Jennette, Alexander Bragat, Jeff Castelli, Sheela Sitaraman, David J. Lockhart, Pol F. Boudes

ORPHANET JOURNAL OF RARE DISEASES (2012)

Add to Collection

Article Pharmacology & Pharmacy